Latest 5 articles from heartwire
- Air pollutants mediate effects on heart health through inflammation and thrombosis
May 17, 2012 17:15 EDT - Azithromycin may up chance of sudden cardiac death
May 16, 2012 17:00 EDT - So long, Plavix, what a ride! Clopidogrel patent expires
May 16, 2012 14:45 EDT - COMFORTABLE-AMI: Bioerodable polymer DES trumps bare metal in STEMI
May 16, 2012 10:50 EDT - COMPARE II: Nobori biolimus stent matches everolimus stents in all-comers
May 16, 2012 10:15 EDT
Anticoagulation during pregnancy: What are we to do?
Posted Dec 17, 2009
at 10:30 AM, EDT
by Samuel Goldhaber
Pregnant women who require anticoagulation are in a quandary. In the US, most pregnant women are directed to discontinue warfarin as soon as pregnancy is confirmed due to the teratogenic effects that it can cause on the fetus.
Alternative anticoagulant strategies have not been extensively tested due to a fear of liability amongst sponsors and investigators and this has left a substantial unmet need for further comprehensive trials.
What is the solution? Could government incentives help?
Previous posts
Should we prescribe novel anticoagulants or warfarin as first line agents for stroke prevention in AF?
4 Comments |
Posted May 06, 2012
at 01:25 PM, EDT by Samuel
at 01:25 PM, EDT by Samuel
Recent PE thrombolysis trials: MAPPET, MOPETT, and MUPPET, with Dr Stavros Konstantinides
No comments |
Posted Apr 27, 2012
at 11:55 AM, EDT by Samuel
at 11:55 AM, EDT by Samuel
The US Postal Service promotes heart health
No comments |
Posted Apr 20, 2012
at 01:50 PM, EDT by Samuel
at 01:50 PM, EDT by Samuel
Thrombolysis in acute pulmonary embolism: An update with Dr Stavros Konstantinides
No comments |
Posted Apr 04, 2012
at 03:08 PM, EDT by Samuel
at 03:08 PM, EDT by Samuel
Einstein PE: Rivaroxaban shines as viable monotherapy for pulmonary embolism
1 Comments |
Posted Mar 26, 2012
at 10:25 AM, EDT by Samuel
at 10:25 AM, EDT by Samuel
Also from theheart.org
Blogs I read
Who's Talking
Samuel Z Goldhaber, MD
Professor of Medicine
Harvard Medical School
Director, Venous Thromboembolism Research Group
Co-Director, Anticoagulation Management Service
Cardiovascular Division
Brigham and Women's Hospital
Boston, MA
Professor of Medicine
Harvard Medical School
Director, Venous Thromboembolism Research Group
Co-Director, Anticoagulation Management Service
Cardiovascular Division
Brigham and Women's Hospital
Boston, MA














Comments